The system was tested with four patients with complete locked-in syndrome who couldn’t even move their eyes to communicate and had amyotrophic lateral sclerosis (ALS).
ALS is a neurodegenerative disease affecting nerve cells in the brain and spinal cord. Motor neurons get transported through the body to the spinal cord and to muscles. When the motor neurons begin to degenerate and die, the brain loses the ability to initiate and control muscle movement. Approximately 20,000 Americans have ALS, with 15 new cases occurring daily, according to the ALS Association.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.